SG10201406571YA - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SG10201406571YA SG10201406571YA SG10201406571YA SG10201406571YA SG10201406571YA SG 10201406571Y A SG10201406571Y A SG 10201406571YA SG 10201406571Y A SG10201406571Y A SG 10201406571YA SG 10201406571Y A SG10201406571Y A SG 10201406571YA SG 10201406571Y A SG10201406571Y A SG 10201406571YA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25102309P | 2009-10-13 | 2009-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201406571YA true SG10201406571YA (en) | 2014-11-27 |
Family
ID=43876821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201406571YA SG10201406571YA (en) | 2009-10-13 | 2010-10-12 | Pharmaceutical compositions |
Country Status (15)
Country | Link |
---|---|
US (2) | US20120208857A1 (en) |
EP (2) | EP3095445A1 (en) |
JP (3) | JP2013507443A (en) |
KR (1) | KR101791709B1 (en) |
CN (1) | CN102573840A (en) |
AU (2) | AU2010307054A1 (en) |
BR (1) | BR112012008649A2 (en) |
CA (1) | CA2776310A1 (en) |
EA (1) | EA022765B1 (en) |
IL (1) | IL219018A (en) |
MX (1) | MX337145B (en) |
NZ (1) | NZ599151A (en) |
SG (1) | SG10201406571YA (en) |
UA (1) | UA111145C2 (en) |
WO (1) | WO2011046905A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2642996T (en) * | 2010-11-24 | 2020-12-30 | Melinta Subsidiary Corp | Pharmaceutical compositions |
CN104784113B (en) * | 2015-04-30 | 2017-09-29 | 成都国为生物医药有限公司 | A kind of composition containing Linezolid and preparation method thereof |
US11112370B2 (en) * | 2019-01-04 | 2021-09-07 | The Boeing Company | Reconfigurable backscatter detector |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
PE20011088A1 (en) * | 2000-03-22 | 2001-10-04 | Upjohn Co | TREATMENT OF URINARY TRACT INFECTIONS WITH ANTIBACTERIAL OXAZOLIDINONES |
MY127336A (en) * | 2000-03-22 | 2006-11-30 | Upjohn Co | Container for linezolid iv solution |
BR0111280A (en) | 2000-06-05 | 2003-06-10 | Dong A Pharm Co Ltd | New oxazolidinone derivatives and a process for their preparation |
MY137618A (en) * | 2000-08-22 | 2009-02-27 | Pharmacia Corp | Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading |
US6696426B2 (en) * | 2000-08-22 | 2004-02-24 | Pharmacia Corporation | Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems |
PE20020300A1 (en) * | 2000-08-22 | 2002-05-10 | Pharmacia Corp | COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD |
JP2007525468A (en) * | 2003-06-03 | 2007-09-06 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | Sulfonamide compounds and methods for producing and using the same |
US6969726B2 (en) | 2003-06-03 | 2005-11-29 | Rib X Pharmaceuticals Inc | Biaryl heterocyclic compounds and methods of making and using the same |
AR046782A1 (en) | 2003-12-17 | 2005-12-21 | Rib X Pharmaceuticals Inc | HALEROCICLY COMPOUNDS OF HALOGENATED BIARILO, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHODS FOR THEIR ELABORATION AND ITS USE AS MEDICATIONS. |
KR100854211B1 (en) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | Novel oxazolidinone derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same for antibiotics |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US7696211B2 (en) * | 2005-04-29 | 2010-04-13 | Wilson Constance N | Methods and pharmaceutical compositions for treating sepsis |
US20070249577A1 (en) * | 2005-05-10 | 2007-10-25 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
WO2007086011A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefepime, tazobactam and linezolid |
WO2007133803A2 (en) * | 2006-05-15 | 2007-11-22 | Rib-X Pharmaceuticals, Inc. | Treatment of mycobacterial infections |
US20080139563A1 (en) * | 2006-10-23 | 2008-06-12 | Concert Pharmaceuticals Inc. | Oxazolidinone derivatives and methods of use |
WO2008085913A1 (en) | 2007-01-04 | 2008-07-17 | Rib-X Pharmaceuticals, Inc. | Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
-
2010
- 2010-10-12 US US13/501,220 patent/US20120208857A1/en not_active Abandoned
- 2010-10-12 SG SG10201406571YA patent/SG10201406571YA/en unknown
- 2010-10-12 UA UAA201205788A patent/UA111145C2/en unknown
- 2010-10-12 NZ NZ599151A patent/NZ599151A/en not_active IP Right Cessation
- 2010-10-12 EP EP16159431.2A patent/EP3095445A1/en not_active Withdrawn
- 2010-10-12 EA EA201270547A patent/EA022765B1/en not_active IP Right Cessation
- 2010-10-12 CN CN2010800462049A patent/CN102573840A/en active Pending
- 2010-10-12 EP EP10823926.0A patent/EP2488175A4/en not_active Withdrawn
- 2010-10-12 WO PCT/US2010/052263 patent/WO2011046905A2/en active Application Filing
- 2010-10-12 AU AU2010307054A patent/AU2010307054A1/en not_active Abandoned
- 2010-10-12 JP JP2012534277A patent/JP2013507443A/en active Pending
- 2010-10-12 MX MX2012004282A patent/MX337145B/en active IP Right Grant
- 2010-10-12 BR BR112012008649A patent/BR112012008649A2/en not_active IP Right Cessation
- 2010-10-12 CA CA2776310A patent/CA2776310A1/en not_active Abandoned
- 2010-10-12 KR KR1020127012191A patent/KR101791709B1/en active IP Right Grant
-
2012
- 2012-04-03 IL IL219018A patent/IL219018A/en not_active IP Right Cessation
-
2015
- 2015-02-24 US US14/630,584 patent/US20150165040A1/en not_active Abandoned
- 2015-06-04 JP JP2015113698A patent/JP2015155479A/en active Pending
-
2016
- 2016-09-27 AU AU2016234893A patent/AU2016234893A1/en not_active Abandoned
-
2017
- 2017-04-12 JP JP2017078885A patent/JP2017141285A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20150165040A1 (en) | 2015-06-18 |
WO2011046905A2 (en) | 2011-04-21 |
JP2013507443A (en) | 2013-03-04 |
BR112012008649A2 (en) | 2021-11-03 |
EP2488175A2 (en) | 2012-08-22 |
US20120208857A1 (en) | 2012-08-16 |
CA2776310A1 (en) | 2011-04-21 |
AU2010307054A1 (en) | 2012-04-26 |
CN102573840A (en) | 2012-07-11 |
KR20120099676A (en) | 2012-09-11 |
EA201270547A1 (en) | 2012-12-28 |
IL219018A (en) | 2016-11-30 |
AU2016234893A1 (en) | 2016-10-20 |
IL219018A0 (en) | 2012-06-28 |
EA022765B1 (en) | 2016-02-29 |
KR101791709B1 (en) | 2017-10-30 |
NZ599151A (en) | 2014-07-25 |
UA111145C2 (en) | 2016-04-11 |
JP2017141285A (en) | 2017-08-17 |
JP2015155479A (en) | 2015-08-27 |
MX2012004282A (en) | 2012-05-22 |
MX337145B (en) | 2016-02-15 |
EP3095445A1 (en) | 2016-11-23 |
EP2488175A4 (en) | 2013-08-07 |
WO2011046905A3 (en) | 2011-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1231408A1 (en) | Pharmaceutical composition | |
HK1218881A1 (en) | Pharmaceutical compositions | |
EP2451274A4 (en) | Pharmaceutical compositions | |
EP2240022A4 (en) | Pharmaceutical compositions | |
EP2373681A4 (en) | Pharmaceutical compositions | |
EP2379077A4 (en) | Pharmaceutical composition | |
GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
IL219018A0 (en) | Pharmaceutical compositions | |
GB0919650D0 (en) | Pharmaceutical composition | |
GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
GB0800659D0 (en) | Pharmaceutical Compositions | |
GB0910225D0 (en) | Pharmaceutical compositions | |
GB0908970D0 (en) | Local pharmaceutical compositions | |
HU0900010D0 (en) | Improved pharmaceutical composition | |
GB0902428D0 (en) | Pharmaceutical methods & compositions | |
GB0921139D0 (en) | Pharmaceutical methods & compositions | |
GB0908069D0 (en) | Pharmaceutical compounds and compositions | |
GB0919055D0 (en) | Pharmaceutical compounds and compositions | |
GB0903945D0 (en) | Pharmaceutical compounds and compositions | |
GB0902651D0 (en) | Pharmaceutical compounds and compositions | |
GB0802024D0 (en) | Pharmaceutical compositions | |
GB0806156D0 (en) | Pharmaceutical compositions | |
GB0806283D0 (en) | Pharmaceutical compositions | |
EP2308842A4 (en) | Pharmaceutical compositions |